SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-414943"
 

Search: onr:"swepub:oai:DiVA.org:uu-414943" > Neuroendocrine Neop...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Neuroendocrine Neoplasms of the Small Bowel and Pancreas

Clift, Ashley Kieran (author)
Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England.
Kidd, Mark (author)
Wren Labs, Branford, CT USA.
Bodei, Lisa (author)
Mem Sloan Kettering Canc Ctr, Dept Nucl Med, 1275 York Ave, New York, NY 10021 USA.
show more...
Toumpanakis, Christos (author)
Royal Free Hosp, Ctr Gastroenterol, Neuroendocrine Tumour Unit, London, England.
Baum, Richard P. (author)
Zent Klin, Theranost Ctr Mol Radiotherapy & Precis Oncol, Bad Berka, Germany.
Öberg, Kjell, 1946- (author)
Uppsala universitet,Endokrin tumörbiologi
Modlin, Irvin M. (author)
Yale Univ, Sch Med, New Haven, CT USA.
Frilling, Andrea (author)
Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England.
show less...
Imperial Coll London, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0HS, England Wren Labs, Branford, CT USA. (creator_code:org_t)
2019-09-27
2020
English.
In: Neuroendocrinology. - : S. Karger. - 0028-3835 .- 1423-0194. ; 110:6, s. 444-476
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The traditionally promulgated perspectives of neuroendocrine neoplasms (NEN) as rare, indolent tumours are blunt and have been outdated for the last 2 decades. Clear increments in their incidence over the past decades render them increasingly clinically relevant, and at initial diagnosis many present with nodal and/or distant metastases (notably hepatic). The molecular pathogenesis of these tumours is increasingly yet incompletely understood. Those arising from the small bowel (SB) or pancreas typically occur sporadically; the latter may occur within the context of hereditary tumour predisposition syndromes. NENs can also be associated with endocrinopathy of hormonal hypersecretion. Tangible advances in the development of novel biomarkers, functional imaging modalities and therapy are especially applicable to this sub-set of tumours. The management of SB and pancreatic neuroendocrine tumours (NET) may be challenging, and often comprises a multidisciplinary approach wherein surgical, medical, interventional radiological and radiotherapeutic modalities are implemented. This review provides a comprehensive overview of the epidemiology, pathophysiology, diagnosis and treatment of SB and pancreatic NETs. Moreover, we provide an outlook of the future in these tumour types which will include the development of precision oncology frameworks for individualised therapy, multi-analyte predictive biomarkers, artificial intelligence-derived clinical decision support tools and elucidation of the role of the microbiome in NEN development and clinical behaviour.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Keyword

Neuroendocrine tumour
Neuroendocrine neoplasm
Small intestine
Pancreas

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view